Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.44 (
P-glycoprotein
)
13,344
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Carnitine beta-hydroxy-gamma-(trimethylammonio)butyrate - a compound necessary in the peripheral tissues for a transfer of fatty acids for their oxidation within the cell, accumulates in the brain despite low beta-oxidation in this organ. In order to enter the brain, carnitine has to cross the blood-brain barrier formed by capillary endothelial cells which are in close interaction with astrocytes. Previous studies, demonstrating expression of mRNA coding two carnitine transporters -
organic cation/carnitine transporter 2
(
OCTN2
) and B(0,+) in endothelial cells, did not give any information on carnitine transporters polarity in endothelium. Therefore more detailed experiments were performed on expression and localization of a high affinity carnitine transporter
OCTN2
in an in vitro model of the blood-brain barrier by real-time PCR, western blot analysis, and immunocytochemistry. The amount of mRNA was comparable in endothelial cells and kidney, when referred to house-keeping genes, it was, however, significantly lower in astrocytes. Polarity of
OCTN2
localization was further studied in an in vitro model of the blood-brain barrier with use of anti-
OCTN2
antibodies. Z-axis analysis of the confocal microscope pictures of endothelial cells, with anti-
P-glycoprotein
antibodies as the marker of apical membrane, showed
OCTN2
localization at the basolateral membrane and in the cytoplasmic region in the vicinity of nuclei. Localization of
OCTN2
suggest that carnitine can be also transported from the brain, playing an important role in removal of certain acyl esters.
...
PMID:Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier. 1799 36